Article Information
History
- March 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zhe Zhang1,*,
- Shipo Wu1,*,
- Yawei Liu2,*,
- Kailiang Li2,*,
- Pengfei Fan1,*,
- Xiaohong Song1,
- Yudong Wang1,
- Zhenghao Zhao1,
- Xianwei Zhang2,
- Jin Shang2,
- Jinlong Zhang1,
- Jinghan Xu1,
- Yao Li1,
- Yaohui Li1,
- Jipeng Zhang2,
- Kefan Fu2,
- Busen Wang1,
- Meng Hao1,
- Guanying Zhang1,
- Pengwei Long2,
- Ziyu Qiu2,
- Tao Zhu3,
- Shuling Liu1,
- Yue Zhang1,
- Fangze Shao1,
- Peng Lv1,
- Yilong Yang1,
- Xiaofan Zhao1,
- Yufa Sun2,#,
- Lihua Hou1,# and
- Wei Chen1,#
- 1Beijing Institute of Biotechnology, Beijing, China
- 2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
- 3CanSino Biologics Inc., Tianjin, China
- ↵#Corresponding authors. E-mail: dafa20136725{at}163.com; houlihua{at}sina.com; cw0226{at}foxmail.com;
↵* These authors contributed equally to this work.
Posted March 10, 2022.
Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming
